Opioid Prescribing for Subacute and Chronic Pain
Ohio has passed rules for the prescribing of opioids for subacute and Chronic Pain
Opioid Prescribing for Acute Pain
Ohio has passed rules limiting the duration of initial opioid prescriptions for acute pain to 5-7 days and the morphine milligram equivalents to 30MED average.
- Rules: Prescribing Opioids for Acute Pain
- Guidance for Acute Pain Prescribing Rules (FAQs)
- Educational Video
Ohio Guidelines for Prescribing Opioids for the Treatment of Chronic, Non-Terminal Pain
A guideline for the use of opioids for the treatment of chronic, non-terminal pain. ”Chronic pain” means pain that has persisted after reasonable medical efforts have been made to relieve the pain or cure its cause and that has continued, either continuously or episodically, for longer than three continuous months. Released by the Governor’s Cabinet Opiate Action Team (GCOAT) in October 2013.
Ohio Emergency and Acute Care Facility Opioids and Other Controlled Substances Prescribing Guidelines
The Ohio Emergency and Acute Care Facility Opioids and Other Controlled Substances Prescribing Guidelines offer clinical guidance for the acute care environment where there is no established patient-doctor relationship. Released by the Governor’s Cabinet Opiate Action Team (GCOAT) in April 2012 and updated in January 2014.
Ohio Guideline for the Management of Acute Pain Outside of Emergency Departments
A guideline for a general approach to the outpatient management of acute pain. Released by the Governor’s Cabinet Opiate Action Team (GCOAT) in January 2016.
Ohio Opioid Prescribing Guidelines
This is a link to a summary document explaining the intent, background and origin of the GCOAT guidelines.
Non-Opioid Treatments for Chronic Pain
CDC fact sheet for healthcare providers that describes pain management alternatives to prescribing opioids for patients’ chronic pain.
The American Society of Addiction Medicine Criteria
The ASAM criteria is most widely used and comprehensive set of guidelines for placement, continued stay and transfer/discharge of patients with addiction and co-occurring conditions.
Prevention of Neonatal Abstinence Syndrome
Recommendations endorsed by the Nursing, Pharmacy and Medical Boards for the prevention of Neonatal Abstinence Syndrome. Prescription drug dependency is harming pregnant women and their children at alarming rates.
Prescribing of Buprenorphine to Treat Opioid Addiction Authorization Expanded to Qualified Certified Nurse Practitioners
The Substance Abuse and Mental Health Services Administration (SAMHSA) recently announced that beginning in early 2017 Certified Nurse Practitioner (CNPs) can obtain training and apply to become DATA-waiver practitioners to prescribe buprenorphine to treat opioid addiction, also known as medication-assisted treatment or MAT.
Institute for Healthcare Improvement Opioid Resources
For even more information on how health care can help turn the tide, please take advantage of IHI’s resources on this topic.
NTSB Issues Recommendations for Healthcare Providers
A recommendation that health care providers discuss with patients the effect their medical condition and medication use may have on their ability to safely operate a vehicle in any mode of transportation.